Recruiting studies: Allergic Conjunctivitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface
Phase N/A · 2 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT04198740 Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
Phase 3 · 2 location(s) · Regeneron Pharmaceuticals · NCT07309432 An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCED
Phase 3 · 77 location(s) · Dompé Farmaceutici S.p.A · NCT07519902 Kelulut Honey for Allergic Conjunctivitis and Dry Eye Symptoms
NA · 1 location(s) · Universiti Sains Malaysia · NCT07273747 A Study to Compare the Effectiveness and Safety of T1695 Versus Ciclosporin in Participants With Moderate to Severe Vern
Phase 2 · 11 location(s) · Laboratoires Thea · NCT07169695 3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis
Phase 3 · 1 location(s) · The University of Hong Kong · NCT06903884 Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis
Phase 2 · 1 location(s) · Telios Pharma, Inc. · NCT06686472 Evaluation of TL-925 for the Treatment of Seasonal Allergic Conjunctivitis
Phase 2 · 1 location(s) · Telios Pharma, Inc. · NCT07220408

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.